🇺🇸 FDA
Patent

US 10792363

Anhydrous sodium thiosulfate and formulations thereof

granted A61KA61K33/04A61K33/243

Quick answer

US patent 10792363 (Anhydrous sodium thiosulfate and formulations thereof) held by Fennec Pharmaceuticals, Inc. expires Mon Oct 01 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Fennec Pharmaceuticals, Inc.
Grant date
Tue Oct 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 01 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K33/04, A61K33/243, A61K47/02, A61K47/18